Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06190730 · ClinicalTrials.gov registry record · NA

REmote Symptom COllection to improVE postopeRative Care

A NA study of Gastrointestinal Cancer and Gastrointestinal Tumor, sponsored by Medstar Health Research Institute.

Recruiting
Registry status
NA
Development phase
281
Enrollment target
2
Study locations

NCT06190730 is a NA study of Gastrointestinal Cancer and Gastrointestinal Tumor that is actively recruiting participants, run by Medstar Health Research Institute. The registered enrollment target is 281 participants, above the 228-participant average among 48 other Gastrointestinal Cancer trials with a reported enrollment target (23% higher). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06190730, a NA study of Gastrointestinal Cancer and Gastrointestinal Tumor, is actively recruiting participants, sponsored by Medstar Health Research Institute.

RECRUITING
Registry status
NA
Development phase
281 participants
Enrollment target
2
Study locations

Study Summary

There are vulnerabilities in post-discharge care transition for patients after undergoing resection of malignant gastrointestinal tumors. This study aims to investigate the possibility of utilizing Voice-Assisted Remote Symptom Monitoring System (VARSMS) to alleviate some of these challenges.

Interventions

  • OTHER Voice-Assisted Remote Symptom Monitoring System (VARSMS)

Study Locations (2)

Maryland

  • MedStar Health - Baltimore

Nebraska

  • Creighton University - Omaha

Trial Details

FieldValue
Enrollment Target 281 participants
Start Date 2024-07-23
Est. Completion 2027-12-31
Phase NA

Sponsor

Medstar Health Research Institute

115 total trials

What the Registry Record Tells You About NCT06190730

The ClinicalTrials.gov registry entry for NCT06190730 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 281 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 228-participant average among 48 other Gastrointestinal Cancer trials with a reported enrollment target (23% higher). The listed sponsor is Medstar Health Research Institute, which has 115 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Gastrointestinal Cancer appearing as the primary indexed condition, and to 1 intervention - of which Voice-Assisted Remote Symptom Monitoring System (VARSMS) is the first listed.

NCT06190730 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Maryland, Nebraska.

Frequently Asked Questions

What is clinical trial NCT06190730 about?

NCT06190730 is a clinical study titled "REmote Symptom COllection to improVE postopeRative Care". There are vulnerabilities in post-discharge care transition for patients after undergoing resection of malignant gastrointestinal tumors. This study aims to investigate the possibility of utilizing Voice-Assisted Remote Symptom Monitoring System (VARSMS) to alleviate some of these challenges.

What is the current status of trial NCT06190730?

This trial is currently recruiting. It is a NA study. The enrollment target is 281 participants. The study started on 2024-07-23. Estimated completion is 2027-12-31.

What conditions does trial NCT06190730 study?

This clinical trial studies the following conditions: Gastrointestinal Cancer, Gastrointestinal Tumor, Gastrointestinal Tumor Surgery, Gastrointestinal Surgery.

What interventions are being tested in trial NCT06190730?

The interventions under investigation include: Voice-Assisted Remote Symptom Monitoring System (VARSMS) (OTHER).

Who is sponsoring clinical trial NCT06190730?

This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06190730 being conducted?

This trial has 2 study locations across Maryland, Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gastrointestinal Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.